In MM pathogenesis, RAS/RAF/MERK/ERK-pathway mutations account for most of the pathway overactivation while there are still some hyperactivation cannot be explained by gene mutation [14]. This evidence concerns the gene MAPK1 and Miyoshi myopathy.